Enzalutamide With or Without Abiraterone Acetate and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by Alliance for Clinical Trials in Oncology
Sponsor:
Collaborators:
Astellas Pharma US, Inc.
Medivation, Inc.
Biologics, Inc.
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology
ClinicalTrials.gov Identifier:
NCT01949337
First received: September 20, 2013
Last updated: May 14, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2019 (Final data collection date for primary outcome measure)